Therapeutic Hypothermia for Cardiac Arrest by Sadaka, Farid
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 2 
 
 
 
 
© 2013 Sadaka, licensee InTech. This is an open access chapter distributed under the terms of the Creative 
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
Therapeutic Hypothermia for Cardiac Arrest 
Farid Sadaka 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/49374 
1. Introduction 
In the era before Therapeutic Hypothermia (TH) was recommended and used as a 
therapeutic modality for out-of-hospital cardiac arrest (OHCA) patients, reported data 
suggests in-hospital mortality exceeded 58%.[1,2,3,4,5,6] Mortality after a sudden and 
unexpected cardiac arrest (CA) is high, and the chance of survival to hospital discharge has, 
until recently, remained unchanged.[7] In one report, OHCA in the U.S. has a mortality rate 
greater than 90% which results in more than 300,000 deaths per year.[8] Those who survive 
the devastating event, often retain a hypoxic brain injury and a permanently incapacitating 
neurologic deficit.[9] Studies of patients who survived to ICU admission but subsequently 
died in the hospital, brain injury was the cause of death in 68% after out-of-hospital cardiac 
arrest and in 23% after in-hospital cardiac arrest.[10,11] Therapeutic hypothermia, or targeted 
temperature management,  is a therapeutic intervention that is intended to limit neurologic 
injury after a patient’s resuscitation from cardiac arrest. 
2. Mechanisms of neuroprotection 
A cascade of destructive events and processes begins at the cellular level in the minutes to 
hours following an initial injury. These processes, the result of ischemia and reperfusion, 
may continue for hours to many days after the initial injury.[12] It is crucial to note that all of 
these processes after ischemic-reperfusion injury in the brain are temperature dependent; 
they are all stimulated by fever, and can all be mitigated or blocked by hypothermia. Since 
most of these processes start within minutes to hours after the injury, then application of 
hypothermia earlier might be even more beneficial than conventional later application. 
2.1. Slowing of brain metabolism 
When hypothermia was first used in a clinical setting it was presumed that its protective 
effects were due purely to a slowing of cerebral metabolism, leading to reduced glucose and 
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oxygen consumption. Cerebral metabolism decreases by 6% to 10% for each 1°C reduction 
in body temperature during cooling.[13,14] This could play a therapeutic effect, but only 
partially. This mechanism is not the only explanation for the dramatic difference seen 
despite the positive role of metabolic slowing in neuroprotection. 
2.2. Inhibition of apoptosis 
Therapeutic hypothermia can also effectively inhibit apoptosis [15-17 ]Hypothermia inhibits 
the early stages of the programmed cell death process.[16] Thus, inhibiting apoptosis is 
another mechanism by which therapeutic hypothermia could influence the ischemia 
reperfusion injury or secondary injury early on in the disease process.  
2.3. Inhibition of excitotoxicity 
Excitatory processes play a major role in the pathophysiology of secondary injury post-
cardiac arrest.[13] Evidence suggests that hypothermia inhibits these harmful excitatory 
processes occurring in brain cells during ischemia–reperfusion. Ischemic insult to the brain 
leads to decrease in Adenosine triphosphate (ATP) supplies.[13] This culminates into an 
influx of calcium (Ca) into the cell through prolonged glutamate exposure inducing a 
permanent state of hyperexcitability in the neurons (excitotoxicity). All these processes are 
inhibited  by hypothermia very early after injury. Some animal experiments suggest that 
neuroexcitotoxicity can be blocked or reversed only if the treatment is initiated in the very 
early stages of the neuroexcitatory cascade.[18-24] 
2.4. Antiinflammatory role and decrease in free radical formation 
Acute inflammation early after return of spontaneous circulation (ROSC) plays a harmful 
role in postcardiac arrest, including cytokines, macrophages, neutrophils, and complement 
activation , leading to free radical formation. Multiple animal experiments and few clinical 
studies have shown that hypothermia suppresses all these ischemia-induced inflammatory 
reactions, leading to a significant reduction in free radical formation. [25-28]  
2.5. Protection of blood-brain barrier 
Ischemia–reperfusion can also lead to significant disruptions in the blood– brain barrier, 
which can facilitate the subsequent development of brain edema. Mild hypothermia 
significantly reduces blood– brain barrier disruptions, and also decreases vascular 
permeability following ischemia–reperfusion, further decreasing edema formation.[29-31]  
2.6. Antithrombotic role 
The coagulation cascade is also activated with ischemia-reperfusion injury leading to  
intravascular clot formation resulting in microvascular thrombosis in the brain.[32,33] 
Therapeutic Hypothermia could be beneficial in this instance since platelets number and 
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function are decreased with temperatures <35°C, and some inhibition of the coagulation 
cascade develops at temperatures <33°C.[34,35] Vasoconstriction , mediated mainly by 
thromboxane and endothelin plays a pivotal role in the secondary injury as well. This could 
also be mitigated by hypothermia [36-38]  
3. Clinical evidence 
3.1. Out of hospital and ventricular fibrillation cardiac arrest  
The first major clinical trials that provided direct evidence of a benefit of therapeutic 
hypothermia were published in 2002. These studies have indicated that TH with a reduction 
of body core temperature (T) to 33 °C over 12 to 24 hours has improved survival and 
neurologic outcome in OHCA patients. The European Hypothermia after Cardiac Arrest 
Study Group demonstrated an improvement in survival from witnessed V-fib cardiac arrest 
from 41% to 55% and an improvement in favorable neurologic outcome among survivors 
from 39% to 55% when TH of 32-34°C was maintained for the first 24 hours post cardiac 
arrest.39 Bernard demonstrated similar neurologic outcome benefits from 12 hours of TH at 
32-34°C induced on the same patient population in Australia.40 Recently, a meta-analysis 
showed that therapeutic hypothermia is associated with a risk ratio of 1.68 (95% CI,1.29-
2.07) favoring a good neurologic outcome when compared with normothermia. The meta-
analysis concluded the number needed to treat (NNT) to produce one favorable 
neurological recovery was 6.41 This would translate to improved neurological recovery in > 
10,000 patients per year in the U.S.41 Findings were also reviewed from recent literature on 
the postresuscitation care of cardiac arrest patients using therapeutic hypothermia as part of 
nontrial treatment. Although varied in their protocols and outcome reporting, results from 
published investigations confirmed the findings from the landmark randomized controlled 
trials, in that the use of therapeutic hypothermia increased survival and favorable 
neurologic outcome.[42]  
3.2. In hospital and non-ventricular fibrillation cardiac arrest 
Although ROSC rates are higher in patients with VF and these represent the majority of 
patients transported to the hospital, many patients still present to the hospital comatose 
after resuscitation from non-VF arrest. Patients with an initial cardiac rhythm of asystole 
have a lower rate of survival than patients with VF, because total absence of rhythm is 
associated with worse underlying causes. Some evidence has now shown that the treatment 
may be beneficial in cases with non-VF initial rhythm.[43-47] However, other studies involving 
this patient population did not show outcome benefit. In a recent study of TH after 
inhospital cardiac arrest (IHCA), 91%of patients had an arrest rhythm of asystole or 
pulseless electrical activity. No difference in neurological outcome at discharge was detected 
in these non-shockable IHCA patients treated with TH.48 Given this increased severity of 
neurological injury in non-VF arrest patients, the possible role of TH remains uncertain. 
Given such low rates of recovery after non-VF arrest with the use of TH, a prospective study 
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comparing TH with normothermia in patients with an initial cardiac rhythm asystole or 
PEA would require very large numbers of patients to get enough power to show improved 
outcomes, and thus is unlikely that such trials will be conducted. 
3.3. Asphyxial causes of cardiac arrest 
Suffocation is the second leading cause of death from suicide in the United States, 
accounting for 22.5% of the 33 300 suicide-related deaths.[49] Victims of near-hanging may 
carry a poor prognosis even if cardiac arrest has not occurred. Those who suffer cardiac 
arrest, present with a Glasgow Coma Scale (GCS) of 5 or less, and experience a longer 
hanging time have the worst prognosis.[50,51]Nearhanging is defined as an unsuccessful 
attempt at hanging. Victims of near-hanging suffer from strangulation with cerebral 
ischemia-reperfusion injury rather than a fatal cervical spine injury. Therapeutic 
Hypothermia has not been prospectively studied in this patient population, and it is 
doubtful that large randomized, controlled trials comparing TH with normothermia will be 
conducted. There are few retrospective reviews and case reports and case series on 
asphyxiated patients with or without cardiac arrests  who had good neurologic recovery 
after therapeutic hypothermia.[52-55] Although it would be difficult to conduct good 
prospective studies, the compiling case studies, anecdotal evidence, and extrapolated data 
support the use of therapeutic hypothermia for asphyxial cardiac arrest until more evidence 
can be obtained. 
4. Guidelines 
In 2005, guidelines for resuscitation and emergency cardiac care of the European 
Resuscitation Council and the American Heart Association  recommended that the core 
body temperature of unconscious adult patients with spontaneous circulation after a VF 
OHCA should be lowered to 32 to 34°C (Class IIA recommendation).[56] Cooling should be 
started as soon as possible after the arrest and should be continued for at least 12 to 24 
hours. 
The guidelines note that patients who have had a cardiac arrest due to nonshockable 
rhythms and patients who have had a cardiac arrest in the hospital may also benefit from 
induced hypothermia (Class IIB recommendation).56  
With more evidence and trials showing the feasibility and the evidence supporting TH for 
cardiac arrest patients, the new guidelines by European Resuscitation Council and the 
American Heart Association in 2010 recommend that comatose (ie, lack of meaningful 
response to verbal commands) adult patients with ROSC after out-of-hospital VF cardiac 
arrest should be cooled to 32°C to 34°C (89.6°F to 93.2°F) for 12 to 24 hours (Class I).[57] 
Induced hypothermia also may be considered for comatose adult patients with ROSC after 
in-hospital cardiac arrest of any initial rhythm or after out-of-hospital cardiac arrest with an 
initial rhythm of pulseless electrical activity or asystole (Class IIb).[57] Active rewarming 
should be avoided in comatose patients who spontaneously develop a mild degree of 
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hypothermia (32°C [89.6°F]) after resuscitation from cardiac arrest during the first 48 hours 
after ROSC. (Class III).[57] 
5. Cooling methods 
5.1. Methods for induction of therapeutic hypothermia 
Bernard et al., reported the results of a clinical trial of the rapid infusion of large-volume (30 
ml/kg), ice-cold (4°C) lactated ringer’s solution in comatose survivors of OHCA. This study 
found that this approach decreased core temperature by 1.6°C over 25 minutes with no 
adverse events.[58] Polderman, et al., used in addition to surface cooling, 30ml/kg (mean 2.3 
liters) of cold normal saline over 50 minutes that showed similar results.[59] Several small 
randomized trials, and nonrandomized observational and retrospective trials, looked at pre-
hospital cooling initiation for patients with OHCA with large-volume ice-cold (4°C) fluids 
(discussed in more detail in a separate chapter: Prehospital Therapeutic Hypothermia for 
Cardiac Arrest).[60-68] All these studies documented the safety and feasibility if ice-cold fluids 
for the rapid induction of therapeutic hypothermia. Other promising methods for induction 
of hypothermia include transnasal cooling device [69], self-adhesive cooling pads [70], and 
cranial cooling caps.[71] 
5.2. Methods for maintenance of therapeutic hypothermia 
An ideal cooling method would be one that will help with rapid induction of cooling, cost-
effective, easily implemented, safe, effective, and able to maintain the temperature with 
minimal variations. 
5.2.1. Surface cooling 
Ice packs are still used in some centers for induction and maintenance of hypothermia, by 
applying them to the head, neck, torso and extremities. Disadvantages of this method 
include slow cooling rate, labor-intensive for the nurses, and wide fluctuations with 
overshooting and undercooling or unintentional rewarming.[40,72,73] 
An effective surface cooling system uses cooling blanket (Arctic Sun, Medivance, Louisville, 
CO, USA). This technology can cool as fast as 1.2°C per hour through especially designed 
pads, is radiolucent (can be used during cardiac catheterization),  has minimal temperature 
variation (operates with feedback control),  and can perform active controlled rewarming.  
The pads can be applied easily by the nurses. Disadvantages include expense, possible skin 
sloughing, and slower cooling rates in very obese people.[72,74] 
A promising technology is the Thermosuit System (Life Recovery Systems, Kinnelon, NJ, 
USA), which surrounds patients directly with cool water and also possesses a feedback 
control mechanism. Animal studies suggest that it provides a cooling rate of 9.7°C per hour 
in 30-kg pigs, versus 3.0°C per hour in humans. Disadvantages include expense and 
hindering appropriate physical exams.[75,76] 
 
Therapeutic Hypothermia in Brain Injury 28 
5.2.2. Intravascular cooling 
The CoolGard System (Alsius, Irvine, CA, USA) is one of the products that uses 
Intravascular devices. This technology works by exchanging heat through a catheter 
containing circulating saline at a controlled temperature with a feedback of patient 
temperature. This technology can cool as fast as 1 to 1.5 °C per hour, is very good at 
maintaining goal temperature (feedback mechanism) and cal also provide active controlled 
rewarming. Disadvantages are those of central venous catheters (risks of bleeding, vessel 
thrombosis, and catheter-related infection). It also requires placement by a physician, which 
if not readily available, may delay initiation of this important and timely therapy.[77.78] 
Although many devices are available to achieve and maintain therapeutic hypothermia, 
there are no current data recommending one method over another, or comparing them 
against each other. Several factors need to be taken into consideration, such as patient 
factors, nursing factors and nurse to patient ratios, and institutional factors when making a 
decision regarding the optimal method. 
6. Conclusion 
On the basis of current evidence, comatose (ie, lack of meaningful response to verbal 
commands) adult patients with ROSC after out-of-hospital VF cardiac arrest should be 
cooled to 32°C to 34°C (89.6°F to 93.2°F) for 12 to 24 hours, as fast as possible. Therapeutic 
Hypothermia should be strongly considered for other rhythms, for inhospital arrests, and 
for cardiac arrest secondary to asphyxia. Intensivists should be familiar with techniques to 
induce, maintain, and rewarm from therapeutic hypothermia, and select the most 
appropriate method for a given patient, and institution. Research questions for the future 
are whether very early cooling, or longer cooling periods (eg, 72 h), or both can further 
improve outcome. 
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